TP53 and osteosarcoma: In the first report, SJSA‐1 osteosarcoma cells were exposed to four cycles of treatment with 10 μM Nutlin‐3a for 72 hr followed by a recovery period.32 Five unique TP53 mutations not found in the parental cell line were identified in subclones.